Below are recently opened clinical trials that are currently available at Fox Chase Cancer Center. To refer a patient to any of these studies, please call 215-214-1515 or visit FoxChase.org/ClinicalTrials.
Featured Clinical Trials
News
This is a prospective, phase II, single arm investigation for favorable prognosis in p16+ oropharynx cancer patients with either node negative or malignant neck adenopathy with lymphoscintigraphy mapping confined to the ipsilateral neck.
News
Dose Attenuated Chemotherapy in Compromised Patients with Lung Cancer - Clinical Trial
The purpose of this research study is to determine whether specific, planned adjustments to the doses of the drugs before you receive the first dose will make receiving treatment easier (that is to say, fewer side effects) while keeping ...
News
Study of LP-184 in Patients With Advanced Solid Tumors - Clinical Trial
The primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory to standard therapy or for whom no standard therapy is available.
